Citadel Advisors’s NeuroSense Therapeutics Ltd. Warrant NRSNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,711
| Closed | -$7.04K | – | 6636 |
|
|
2024
Q4 | $7.04K | Sell |
22,711
-2,563
| -10% | -$794 | ﹤0.01% | 5745 |
|
|
2024
Q3 | $3.79K | Sell |
25,274
-4,190
| -14% | -$628 | ﹤0.01% | 5537 |
|
|
2024
Q2 | $6.07K | Sell |
29,464
-18,674
| -39% | -$3.85K | ﹤0.01% | 5569 |
|
|
2024
Q1 | $20.2K | Buy |
+48,138
| New | +$20.2K | ﹤0.01% | 5548 |
|
|
2023
Q4 | – | Sell |
-11,588
| Closed | -$1.85K | – | 6417 |
|
|
2023
Q3 | $1.85K | Sell |
11,588
-26,346
| -69% | -$4.22K | ﹤0.01% | 5648 |
|
|
2023
Q2 | $8.96K | Buy |
37,934
+5,323
| +16% | +$1.26K | ﹤0.01% | 5391 |
|
|
2023
Q1 | $9.78K | Buy |
+32,611
| New | +$9.78K | ﹤0.01% | 5520 |
|